ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 61–72 of 2020 project topics
CRISPR Guide RNA Design and Efficiency Testing
Designing optimal guide RNA sequences targeting specific genomic loci and validating editing efficiency using T7E1 assay and next-generation sequencing in cell line models.
CRISPR-Cas Genome Editing Applications Click to view more details →
GWAS Study Design and Sample Size Calculation
Designing case-control GWAS studies with appropriate statistical power calculations for detecting common variant associations with disease phenotypes.
Genome-Wide Association Studies Click to view more details →
CRISPR Base Editing for Precise Gene Correction
Applying cytosine and adenine base editing systems for making precise single nucleotide changes without double-strand breaks for therapeutic gene correction applications.
CRISPR-Cas Genome Editing Applications Click to view more details →
GWAS Data Quality Control and Analysis Pipeline
Developing bioinformatics pipelines for SNP and sample QC, population stratification correction, and association testing in GWAS datasets.
Genome-Wide Association Studies Click to view more details →
CRISPR-Cas12a for Multiplexed Gene Disruption
Using Cas12a-based multiplex gene editing with single CRISPR arrays to simultaneously disrupt multiple genes in metabolic engineering and disease modeling applications.
CRISPR-Cas Genome Editing Applications Click to view more details →
GWAS Signal Fine Mapping and Credible Sets
Applying Bayesian fine mapping and conditional analysis for identifying causal variants within GWAS association signals.
Genome-Wide Association Studies Click to view more details →
CRISPR Activation and Interference for Gene Regulation
Deploying dCas9-based transcriptional activator and repressor systems for programmable gene expression control without permanent genomic modification in research applications.
CRISPR-Cas Genome Editing Applications Click to view more details →
Cross-Trait GWAS and Genetic Correlation Analysis
Using LD score regression and multi-trait analysis for estimating genetic correlations between diseases and identifying shared genetic architecture.
Genome-Wide Association Studies Click to view more details →
CRISPR Off-Target Detection and Mitigation Software Platform
Commercial SaaS platform that predicts, identifies, and validates off-target cutting sites across the genome using machine learning algorithms and experimental validation workflows. Enterprises and biotech firms license this tool to reduce safety risks, accelerate regulatory approval timelines, and minimize costly clinical trial failures.
CRISPR-Cas Genome Editing Applications Click to view more details →
Polygenic Risk Score Development and Clinical Implementation Platform
SaaS platforms that automate PRS construction, validation, and integration into clinical workflows for disease risk stratification and personalized medicine. Enables healthcare providers and insurers to monetize genetic risk assessment through preventive care programs and precision medicine services.
Genome-Wide Association Studies Click to view more details →
GWAS Variant Interpretation and Functional Annotation Tools
Commercial software solutions that leverage computational biology and machine learning to annotate GWAS-identified variants with functional consequences and biological mechanisms. Generates licensing revenue from pharmaceutical companies, genomics labs, and biotech firms requiring variant prioritization for drug discovery pipelines.
Genome-Wide Association Studies Click to view more details →
High-Throughput CRISPR Screening Service for Drug Target Discovery
Industry service offering genome-wide CRISPR knockout and activation libraries combined with next-generation sequencing analysis to identify disease-relevant gene targets at scale. Pharmaceutical and biotech companies pay subscription fees for access to validated target datasets and assay optimization expertise, reducing drug discovery timelines by 12-18 months.
CRISPR-Cas Genome Editing Applications Click to view more details →